Genomictree Inc. (KOSDAQ: 228760)
South Korea
· Delayed Price · Currency is KRW 17,000
+800 (4.94%)
Sep 12, 2024, 11:33 AM KST
Genomictree Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Operating Revenue | 2,038 | 3,418 | 29,866 | 5,140 | 1,239 | 281.63 | Upgrade
|
| Other Revenue | 0 | 0 | - | - | - | 0 | Upgrade
|
| Revenue | 2,038 | 3,418 | 29,866 | 5,140 | 1,239 | 281.63 | Upgrade
|
| Revenue Growth (YoY) | -64.83% | -88.56% | 481.09% | 314.87% | 339.89% | -27.22% | Upgrade
|
| Cost of Revenue | 3,246 | 3,720 | 4,891 | 2,641 | 1,193 | 746.83 | Upgrade
|
| Gross Profit | -1,208 | -301.62 | 24,974 | 2,499 | 46.03 | -465.21 | Upgrade
|
| Selling, General & Admin | 7,760 | 10,936 | 14,024 | 8,524 | 8,242 | 7,843 | Upgrade
|
| Research & Development | 3,869 | 4,366 | 5,446 | 2,812 | 3,510 | 1,641 | Upgrade
|
| Other Operating Expenses | 850.36 | 894.91 | 223.09 | 384.93 | 18.63 | 81.76 | Upgrade
|
| Operating Expenses | 13,183 | 17,002 | 22,569 | 12,354 | 12,455 | 9,843 | Upgrade
|
| Operating Income | -14,391 | -17,303 | 2,405 | -9,855 | -12,409 | -10,308 | Upgrade
|
| Interest Expense | -388.1 | -2,054 | -5,382 | -4,606 | -1,668 | - | Upgrade
|
| Interest & Investment Income | 4,192 | 4,829 | 3,610 | 4,147 | 1,783 | 5,457 | Upgrade
|
| Currency Exchange Gain (Loss) | 286.79 | -21.87 | 498.93 | 831.9 | 52.23 | 319.25 | Upgrade
|
| Other Non Operating Income (Expenses) | 448.68 | 817.71 | -4,682 | 112.85 | -217.75 | -5,509 | Upgrade
|
| EBT Excluding Unusual Items | -9,851 | -13,733 | -3,550 | -9,369 | -12,459 | -10,041 | Upgrade
|
| Gain (Loss) on Sale of Investments | -534.06 | -328.33 | -2,097 | -2,072 | 728.2 | -225.96 | Upgrade
|
| Gain (Loss) on Sale of Assets | -4.46 | - | -92.05 | 17.1 | 8.45 | -0.35 | Upgrade
|
| Other Unusual Items | - | 4,558 | 2,045 | - | - | - | Upgrade
|
| Pretax Income | -10,390 | -9,503 | -3,693 | -11,424 | -11,722 | -10,267 | Upgrade
|
| Income Tax Expense | -496.61 | -496.61 | 2,544 | 0.92 | 0.94 | - | Upgrade
|
| Earnings From Continuing Operations | -9,893 | -9,007 | -6,237 | -11,425 | -11,723 | -10,267 | Upgrade
|
| Minority Interest in Earnings | 329.47 | 250.69 | -393.43 | - | -71.83 | 72.68 | Upgrade
|
| Net Income | -9,564 | -8,756 | -6,631 | -11,425 | -11,795 | -10,195 | Upgrade
|
| Net Income to Common | -9,564 | -8,756 | -6,631 | -11,425 | -11,795 | -10,195 | Upgrade
|
| Shares Outstanding (Basic) | 24 | 22 | 21 | 21 | 20 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 27 | 21 | 21 | 20 | 19 | Upgrade
|
| Shares Change (YoY) | 11.74% | 26.28% | 1.67% | 3.30% | 4.57% | 21.54% | Upgrade
|
| EPS (Basic) | -405.03 | -390.66 | -315.89 | -553.38 | -590.16 | -533.41 | Upgrade
|
| EPS (Diluted) | -538.02 | -448.80 | -316.00 | -553.38 | -590.16 | -533.41 | Upgrade
|
| Free Cash Flow | -15,775 | -11,120 | 2,523 | -18,593 | -12,926 | -11,009 | Upgrade
|
| Free Cash Flow Per Share | -668.12 | -419.50 | 120.20 | -900.62 | -646.74 | -576.03 | Upgrade
|
| Gross Margin | -59.27% | -8.82% | 83.62% | 48.62% | 3.72% | -165.19% | Upgrade
|
| Operating Margin | -705.99% | -506.24% | 8.05% | -191.75% | -1001.61% | -3660.22% | Upgrade
|
| Profit Margin | -469.18% | -256.17% | -22.20% | -222.28% | -952.10% | -3619.97% | Upgrade
|
| Free Cash Flow Margin | -773.93% | -325.32% | 8.45% | -361.76% | -1043.37% | -3909.18% | Upgrade
|
| EBITDA | -13,223 | -16,125 | 3,740 | -8,833 | -11,501 | -9,818 | Upgrade
|
| EBITDA Margin | - | - | 12.52% | -171.86% | - | - | Upgrade
|
| D&A For EBITDA | 1,167 | 1,178 | 1,335 | 1,022 | 907.92 | 490.49 | Upgrade
|
| EBIT | -14,391 | -17,303 | 2,405 | -9,855 | -12,409 | -10,308 | Upgrade
|
| EBIT Margin | - | - | 8.05% | -191.75% | - | - | Upgrade
|
| Advertising Expenses | - | 932.39 | 964.91 | 1,119 | 2,228 | 2,788 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.